Personnel Information

写真a

MATSUMOTO Masahito


Job title

Visiting Lecturer

Mail Address

The inquiry by e-mail is 《here

Homepage URL

http://www.tmd.ac.jp/i-mde/www/biofunctions/biofunctions-e.html

Research Areas, Keywords

molecular biology, regenerative medicine

Graduate School 【 display / non-display

  • The University of Tokyo, Graduate School, Division of Medical Sciences, Doctor's Course, Completed

Campus Career 【 display / non-display

  • 2017.07
    -
    2018.03
    Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Biofunctional Restoration, Material Biofunctions, Visiting Lecturer
  • 2019.01
    -
    2021.09
    Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Biofunctional Restoration, Material Biofunctions, Associate Professor
  • 2020.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Biomedical Sciences and Enginnering Track, Department of Advanced Bio-moecular Design
  • 2022.05
    -
    2023.04
    Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Biofunctional Restoration, Material Biofunctions, Visiting Lecturer
  • 2023.05
    -
    2024.04
    Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Visiting Lecturer
  • 2024.05
    -
    Now
    Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, -, -, Visiting Lecturer

▼display all

External Career 【 display / non-display

  • 2004.04
    -
    2009.10
    Saitama Medical University, Department of Molecular Biology, Junior Associate Professor
  • 2009.01
    -
    2011.01
    Salk Institute, Visiting scientist
  • 2012.04
    -
    2017.12
    RCGM, Saitama Medical University, Division of Genomic Science, Junior Associate Professor
  • 2017.01
    -
    2017.03
    , Visiting assistant professor
  • 2018.01
    -
    2018.12
    Juntendo Univeristy, Advanced Diabetic Therapeutics & Department of Metabolic Endocrinology/Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Center,, Associate Professor
  • 2019.01
    -
    Now
    Juntendo University, Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Center/Department of Metabolic Endocrinology, Visiting associate professor

▼display all

Academic Society Affiliations 【 display / non-display

  • International Society for Stem Cell Research (ISSCR)

Academic Activity 【 display / non-display

  • 2016.06
    -
    Now
    Journal of Molecular and Cellular Biology, Austin Journal, Ediotrial Board Member
  • 2016.12
    -
    2017.12
    Editorial board member
  • 2020.04
    -
    Now
    Graduate School of Medical and Dental Sciences,Tokyo Medical University and Dental University (TMDU) Steering commitee of Biomedical Sciences and Enginnering Track
  • 2021.09
    -
    Now
    SciencePG Science publishing group, Cell Biology Editorial Board Member

Research Areas 【 display / non-display

  • Molecular biology

  • Cell biology

  • Metabolism and endocrinology

 

Published Papers & Misc 【 display / non-display

  1. Yasuoka Y, Matsumoto M, Yagi K, Okazaki Y. Evolutionary History of GLIS Genes Illuminates their Roles in Cell Reprogramming and Ciliogenesis. Molecular Biology and Evolution. 2020.01; 37 (1): 100-109. ( PubMed, DOI )

  2. Kimura-Nakajima C, Sakaguchi K, Hatano Y, Matsumoto M, Okazaki Y, Tanaka K, Yamane T, Oishi Y, Kamimoto K, Iwatsuki K. Ngn3-Positive Cells Arise from Pancreatic Duct Cells. International journal of molecular sciences. 2021.08; 22 (16): ( PubMed, DOI )

  3. Watanabe A, Tanaka A, Koga C, Matsumoto M, Okazaki Y, Kin T, Miyajima A. CD82 is a marker to isolate β cell precursors from human iPS cells and plays a role for the maturation of β cells. Scientific reports. 2021.05; 11 (1): 9530. ( PubMed, DOI )

  4. Sato T, Iwata T, Usui M, Kokabu S, Sugamori Y, Takaku Y, Kobayashi T, Ito K, Matsumoto M, Takeda S, Xu R, Chida D. Bone phenotype in melanocortin 2 receptor-deficient mice. Bone reports. 2020.12; 13 100713. ( PubMed, DOI )

  5. Ohki Junko, Sakashita Akihiko, Aihara Eitaro, Inaba Akihiko, Uchiyama Hironobu, Matsumoto Masahito, Ninomiya Yuzo, Yamane Takumi, Oishi Yuichi, Iwatsuki Ken. Comparative analysis of enteroendocrine cells and their hormones between mouse intestinal organoids and native tissues(和訳中) Bioscience, Biotechnology, and Biochemistry. 2020.05; 84 (5): 936-942. ( ichushi )

  6. Tanaka A, Watanabe A, Nakano Y, Matsumoto M, Okazaki Y, Miyajima A. Reversible expansion of pancreatic islet progenitors derived from human induced pluripotent stem cells. Genes to cells : devoted to molecular & cellular mechanisms. 2020.05; 25 (5): 302-311. ( PubMed, DOI )

  7. Ohki J, Sakashita A, Aihara E, Inaba A, Uchiyama H, Matsumoto M, Ninomiya Y, Yamane T, Oishi Y, Iwatsuki K. Comparative analysis of enteroendocrine cells and their hormones between mouse intestinal organoids and native tissues. Bioscience, biotechnology, and biochemistry. 2020.05; 84 (5): 936-942. ( PubMed, DOI )

  8. Yamashita-Sugahara Y, Tokuzawa Y, Nakachi Y, Kanesaki-Yatsuka Y, Matsumoto M, Mizuno Y, Okazaki Y. Correction: <i>Fam57b</i> (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesis. The Journal of biological chemistry. 2020.04; 295 (15): 5176. ( PubMed, DOI )

  9. Tsuyoshi Sato, Takanori Iwata, Michihiko Usui, Shoichiro Kokabu, Yasutaka Sugamori, Yuki Takaku, Takashi Kobayashi, Ko Ito, Masahito Matsumoto, Shu Takeda, Xu Ren, Dai Chida. Bone phenotype in melanocortin 2 receptor-deficient mice Bone reports. 2020; in press

  10. Matsumoto Masahito, Itaka Keiji. Pax6の骨およびグルコース代謝の調節における細胞分化を介した二重機能の役割 組織培養研究. 2019.06; 38 (2): 59. ( ichushi )

  11. Fink J, Schoenfeld BJ, Hackney AC, Matsumoto M, Maekawa T, Nakazato K, Horie S. Anabolic-androgenic steroids: procurement and administration practices of doping athletes. The Physician and Sportsmedicine. 2019.02; 47 (1): 10-14. ( PubMed, DOI )

  12. Fink J, Matsumoto M, Tamura Y. Potential application of testosterone replacement therapy as treatment for obesity and type 2 diabetes in men. Steroids. 2018.10; 138 161-166. ( PubMed, DOI )

  13. Fink JE, Hackney AC, Matsumoto M, Maekawa T, Horie S. Mobility and Biomechanical Functions in the Aging Male: Testosterone and the Locomotive Syndrome. The aging male : the official journal of the International Society for the Study of the Aging Male. 2018.09; 1-8. ( PubMed, DOI )

  14. Nakajima C, Kamimoto K, Miyajima K, Matsumoto M, Okazaki Y, Kobayashi-Hattori K, Shimizu M, Yamane T, Oishi Y, Iwatsuki K. A Method for Identifying Mouse Pancreatic Ducts. Tissue engineering. Part C, Methods. 2018.08; 24 (8): 480-485. ( PubMed, DOI )

  15. 松本 征仁, 佐藤 毅, 大久保 正彦, 大久保 桃絵, 水野 洋介, 依田 哲也, 岡崎 康司. Kif11は間葉系幹細胞から骨芽細胞への分化を抑制するエピジェネティック制御の標的因子である 生命科学系学会合同年次大会. 2017.12; 2017年度 [3AT11-06(3P. ( ichushi )

  16. Enoki Y, Sato T, Kokabu S, Hayashi N, Iwata T, Yamato M, Usui M, Matsumoto M, Tomoda T, Ariyoshi W, Nishihara T, Yoda T. Netrin-4 Promotes Differentiation and Migration of Osteoblasts. In vivo (Athens, Greece). 2017.09; 31 (5): 793-799. ( PubMed )

  17. Jiang FX, Li K, Archer M, Mehta M, Jamieson E, Charles A, Dickinson JE, Matsumoto M, Morahan G. Differentiation of Islet Progenitors Regulated by Nicotinamide into Transcriptome-Verified β Cells That Ameliorate Diabetes. Stem cells (Dayton, Ohio). 2017.05; 35 (5): 1341-1354. ( PubMed, DOI )

  18. Sato T, Kokabu S, Enoki Y, Hayashi N, Matsumoto M, Nakahira M, Sugasawa M, Yoda T. Functional Roles of Netrin-1 in Osteoblast Differentiation. In vivo (Athens, Greece). 2017.05; 31 (3): 321-328. ( PubMed, DOI )

  19. Enoki Yuichiro, Sato Tsuyoshi, Kokabu Shoichiro, Hayashi Naoki, Iwata Takanori, Yamato Masayuki, Usui Michihiko, Matsumoto Masahito, Tomoda Taketo, Ariyoshi Wataru, Nishihara Tatsuji, Yoda Tetsuya. Netrin-4 Promotes Differentiation and Migration of Osteoblasts IN VIVO. 2017; 31 (5): 793-799. ( DOI )

  20. Yamashita-Sugahara Y, Matsumoto M, Ohtaka M, Nishimura K, Nakanishi M, Mitani K, Okazaki Y. An inhibitor of fibroblast growth factor receptor-1 (FGFR1) promotes late-stage terminal differentiation from NGN3+ pancreatic endocrine progenitors. Scientific reports. 2016.10; 6 35908. ( PubMed, DOI )

  21. 大久保 正彦, 松本 征仁, 水野 洋介, 仲地 豊, 林 直樹, 榎木 祐一郎, 佐藤 毅, 須田 立雄, 依田 哲也, 岡崎 康司. DNAメチル化修飾を介した骨芽細胞分化のエピジェネティクス制御 日本生化学会大会・日本分子生物学会年会合同大会講演要旨集. 2015.12; 88回・38回 [3P0644]. ( ichushi )

  22. Sato T, Enoki Y, Sakamoto Y, Yokota K, Okubo M, Matsumoto M, Hayashi N, Usui M, Kokabu S, Mimura T, Nakazato Y, Araki N, Fukuda T, Okazaki Y, Suda T, Takeda S, Yoda T. Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase. Heliyon. 2015.09; 1 (1): e00013. ( PubMed, DOI )

  23. Sugiyama T, Torio T, Sato T, Matsumoto M, Kim YT, Oda H. Improvement of skeletal fragility by teriparatide in adult osteoporosis patients: a novel mechanostat-based hypothesis for bone quality. Frontiers in endocrinology. 2015; 6 6. ( PubMed, DOI )

  24. Blaabjerg L, Christensen GL, Matsumoto M, van der Meulen T, Huising MO, Billestrup N, Vale WW. CRFR1 activation protects against cytokine-induced β-cell death. Journal of molecular endocrinology. 2014.12; 53 (3): 417-27. ( PubMed, DOI )

  25. Enoki Y, Sato T, Tanaka S, Iwata T, Usui M, Takeda S, Kokabu S, Matsumoto M, Okubo M, Nakashima K, Yamato M, Okano T, Fukuda T, Chida D, Imai Y, Yasuda H, Nishihara T, Akita M, Oda H, Okazaki Y, Suda T, Yoda T. Netrin-4 derived from murine vascular endothelial cells inhibits osteoclast differentiation in vitro and prevents bone loss in vivo. FEBS letters. 2014.06; 588 (14): 2262-9. ( PubMed, DOI )

  26. Kogawa M, Hisatake K, Atkins GJ, Findlay DM, Enoki Y, Sato T, Gray PC, Kanesaki-Yatsuka Y, Anderson PH, Wada S, Kato N, Fukuda A, Katayama S, Tsujimoto M, Yoda T, Suda T, Okazaki Y, Matsumoto M. The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation. The Journal of biological chemistry. 2013.10; 288 (43): 31299-312. ( PubMed, DOI )

  27. Kato Naoki, Matsumoto Masahito, Kogawa Masakazu, Oda Hiromi, Ogata Masato. 末梢神経再生update p38 MAPKシグナル伝達経路を介した神経再生の調節機序(Updates in peripheral nerve regeneration Regulatory mechanisms of nerve regeneration via p38 MAPK signaling pathway) 日本整形外科学会雑誌. 2013.08; 87 (8): S1282. ( ichushi )

  28. Matsumoto Masahito, Kogawa Masakazu, Hisatake Koji, Atkins Gerald, Findlay David, Enoki Yuichiro, Sato Tsuyoshi, Wada Seiki, Fukuda Aya, Katayama Shigehiro, Yoda Tetsuya, Suda Tatsuo, Okazaki Yasushi. Dual functions the role of Pax6 in the regulation of bone and glucose metabolism JOURNAL OF BONE AND MINERAL RESEARCH. 2013.02; 28

  29. Enoki Yuichiro, Sato Tsuyoshi, Matsumoto Masahito, Kokabu Shoichiro, Okubo Masahiko, Iwata Takanori, Usui Michihiko, Fukuda Toru, Takeda Shu, Imai Yuuki, Tanaka Shinya, Oda Hiromi, Suda Tatsuo, Yoda Tetsuya. Vascularendothelial cells inhibit osteoclastogenesis by netrin 4 through DSCAM receptor JOURNAL OF BONE AND MINERAL RESEARCH. 2013.02; 28

  30. Yamashita-Sugahara Y, Tokuzawa Y, Nakachi Y, Kanesaki-Yatsuka Y, Matsumoto M, Mizuno Y, Okazaki Y. Fam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesis. The Journal of biological chemistry. 2013.02; 288 (7): 4522-37. ( PubMed, DOI )

  31. Kato N, Matsumoto M, Kogawa M, Atkins GJ, Findlay DM, Fujikawa T, Oda H, Ogata M. Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo. Journal of neuroinflammation. 2013.01; 10 1. ( PubMed, DOI )

  32. 松本 征仁, Huising Mark, van der Meulen Talitha, 平崎 正孝, 禾 泰壽, Vale Wylie. Notchを介したエピジェネティックな調節は、HB-EGFとCRFファミリーの統合による膵内分泌前駆細胞の維持に重要である(Notch-mediated epigenetic regulation is critical for maintenance of pancreatic endocrine progenitors via possible integration with HB-EGF and CRF-family) 組織培養研究. 2012.03; 31 (1): 35. ( ichushi )

  33. Huising MO, van der Meulen T, Vaughan JM, Matsumoto M, Donaldson CJ, Park H, Billestrup N, Vale WW. CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proceedings of the National Academy of Sciences of the United States of America. 2010.01; 107 (2): 912-7. ( PubMed, DOI )

  34. Uemura Y, Liu TY, Narita Y, Suzuki M, Nakatsuka R, Araki T, Matsumoto M, Iwai LK, Hirosawa N, Matsuoka Y, Murakami M, Kimura T, Hase M, Kohno H, Sasaki Y, Ichihara Y, Ishihara O, Kikuchi H, Sakamoto Y, Jiao SC, Senju S, Sonoda Y. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells. Journal of immunology (Baltimore, Md. : 1950). 2009.07; 183 (1): 201-8. ( PubMed, DOI )

  35. Hikata T, Takaishi H, Takito J, Hakozaki A, Furukawa M, Uchikawa S, Kimura T, Okada Y, Matsumoto M, Yoshimura A, Nishimura R, Reddy SV, Asahara H, Toyama Y. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood. 2009.03; 113 (10): 2202-12. ( PubMed, DOI )

  36. Hikata T., Takaishi H., Matsumoto M., Takayanagi H., Yoshimura A., Asahara H., Toyama Y.. Negatively regulates RANKL-induced osteoclastogenesis JOURNAL OF BONE AND MINERAL RESEARCH. 2007.09; 22 S151.

  37. Matsumoto Masahito. Gradual regulation of osteoclastogenesis mediated by p38 MAP kinase SEIKAGAKU. 2007.02; 79 (2): 140-144.

  38. Imazawa Y, Hisatake K, Mitsuzawa H, Matsumoto M, Tsukui T, Nakagawa K, Nakadai T, Shimada M, Ishihama A, Nogi Y. The fission yeast protein Ker1p is an ortholog of RNA polymerase I subunit A14 in Saccharomyces cerevisiae and is required for stable association of Rrn3p and RPA21 in RNA polymerase I. The Journal of biological chemistry. 2005.03; 280 (12): 11467-74. ( PubMed, DOI )

  39. Masahito Matsumoto, Masakazu Kogawa, Seiki Wada, Hiroshi Takayanagi, Masafumi Tsujimoto, Shigehiro Katayama, Koji Hisatake, Yasuhisa Nogi. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J. Biol. Chem.. 2004.10; 279 (44): 45969-45979. ( PubMed, DOI )

  40. Kogawa Masakazu, Matsumoto Masahito, Hisatake Koji, Tsujimoto Masafumi, Katayama Shigehiro, Nogi Yasuhisa. p38MAPキナーゼを介した転写因子による破骨細胞の分化段階的制御(Gradual regulation of osteoclast differentiation by transcription factors through p38 MAP kinase) 生化学. 2004.08; 76 (8): 970. ( ichushi )

  41. Fukuda A, Nakadai T, Shimada M, Tsukui T, Matsumoto M, Nogi Y, Meisterernst M, Hisatake K. Transcriptional coactivator PC4 stimulates promoter escape and facilitates transcriptional synergy by GAL4-VP16. Molecular and cellular biology. 2004.07; 24 (14): 6525-35. ( PubMed, DOI )

  42. Nakagawa K, Hisatake K, Imazawa Y, Ishiguro A, Matsumoto M, Pape L, Ishihama A, Nogi Y. The fission yeast RPA51 is a functional homolog of the budding yeast A49 subunit of RNA polymerase I and required for maximizing transcription of ribosomal DNA. Genes & genetic systems. 2003.06; 78 (3): 199-209. ( PubMed )

  43. Fukuda A, Tokonabe S, Hamada M, Matsumoto M, Tsukui T, Nogi Y, Hisatake K. Alleviation of PC4-mediated transcriptional repression by the ERCC3 helicase activity of general transcription factor TFIIH. The Journal of biological chemistry. 2003.04; 278 (17): 14827-31. ( PubMed, DOI )

  44. Maruyama S, Sumita K, Shen H, Kanoh M, Xu X, Sato M, Matsumoto M, Shinomiya H, Asano Y. Identification of IFN regulatory factor-1 binding site in IL-12 p40 gene promoter. Journal of immunology (Baltimore, Md. : 1950). 2003.01; 170 (2): 997-1001. ( PubMed, DOI )

  45. M Matsumoto, T Sudo, M Maruyama, H Osada, M Tsujimoto. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor. FEBS Lett.. 2000.12; 486 (1): 23-28. ( PubMed, DOI )

  46. M Matsumoto, T Sudo, T Saito, H Osada, M Tsujimoto. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J. Biol. Chem.. 2000.10; 275 (40): 31155-31161. ( PubMed, DOI )

  47. M Matsumoto, N Tanaka, H Harada, T Kimura, T Yokochi, M Kitagawa, C Schindler, T Taniguchi. Activation of the transcription factor ISGF3 by interferon-gamma. Biol. Chem.. 1999.06; 380 (6): 699-703. ( PubMed, DOI )

  48. Matsumoto M, Tanaka N, Harada H, Kimura T, Yokochi T, Kitagawa M, Schindler C, Taniguchi T. Activation of the transcription factor ISGF3 by interferon-gamma BIOLOGICAL CHEMISTRY. 1999.06; 380 (6): 699-703.

  49. Y Yamano, M Matsumoto, K Sasahara, E Sakamoto, I Morishima. Structure of genes for cecropin A and an inducible nuclear protein that binds to the promoter region of the genes from the silkworm, Bombyx mori. Biosci. Biotechnol. Biochem.. 1998.02; 62 (2): 237-241. ( PubMed )

  50. H Harada, M Matsumoto, M Sato, Y Kashiwazaki, T Kimura, M Kitagawa, T Yokochi, R S Tan, T Takasugi, Y Kadokawa, C Schindler, R D Schreiber, S Noguchi, T Taniguchi. Regulation of IFN-alpha/beta genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-alpha/beta. Genes Cells. 1996.11; 1 (11): 995-1005. ( PubMed )

  51. T Kimura, Y Kadokawa, H Harada, M Matsumoto, M Sato, Y Kashiwazaki, M Tarutani, R S Tan, T Takasugi, T Matsuyama, T W Mak, S Noguchi, T Taniguchi. Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells. 1996.01; 1 (1): 115-124. ( PubMed )

  52. T Kawakami, M Matsumoto, M Sato, H Harada, T Taniguchi, M Kitagawa. Possible involvement of the transcription factor ISGF3 gamma in virus-induced expression of the IFN-beta gene. FEBS Lett.. 1995.01; 358 (3): 225-229. ( PubMed, DOI )

▼display all

Conference Activities & Talks 【 display / non-display

  1. 安岡有理、松本征仁、八木研、岡﨑康司. 初期化因子GLIS1の進化的起源と祖先的役割. 第91回日本動物学会大会 2020.09.04 オンライン開催

  2. Masahito Matsumoto, Keiji Itaka, Yasushi Okazaki.. Integrative screening for identification of cell fate driver for beta cells with endocrine progenitor cell line Tec-3p and trancing model of dual-labeled Ngn3-eGFP/Ins-DsRed mice. 2019.11.17 Toronto Canada

  3. 西村 渉, 安田 和基, 松本征仁, 岡崎 康司, 野田 泰子. 成熟β細胞で抑制されている遺伝子の解析. 第92回 日本生化学会大会 2019.09.18 横浜

  4. 安岡有理、松本征仁、八木研、岡﨑康司. Evolutionary History of GLIS Genes Illustrates their Fundamental Roles in Cell Reprogramming and Ciliogenesis. 第21回日本進化学会年会 2019.08.08 札幌

  5. Matsumoto Masahito, Itaka Keiji. Pax6の骨およびグルコース代謝の調節における細胞分化を介した二重機能の役割. 第92回 組織培養学会 2019.07.04 東京

  6. Fink Julius E., Hackney Anthony C., Matsumoto Masahito, Maekawa Takahiro, Horie Shigeo. 老齢男性における運動性と生体力学的機能. 日本運動療法学会大会 2019.06.22 東京

  7. 松本 征仁, 佐藤 毅, 大久保 正彦, 大久保 桃絵, 水野 洋介, 依田 哲也, 岡崎 康司. Kif11は間葉系幹細胞から骨芽細胞への分化を抑制するエピジェネティック制御の標的因子である. 生命科学系学会合同年次大会 2017.12.07 神戸

  8. Matsumoto M, Oizaki Y. Novel approaches for making beta cells towards beta cell replenishment therapy.. Kyoto Diabetes Mini-symposium-Beta cell replacement strategies 2017.06

  9. Matsumoto M. Novel approaches for making beta cells towards beta cell replenishment therapy. Kyoto Diabetes Mini-symposium-Beta cell replacement strategies 2017.06 Kyoto

  10. 松本征仁. 発生・再生医学的アプローチによる膵臓内分泌細胞の分化調節. 膵島研究所セミナー 2013.11 福岡

  11. Matsumoto M, Huising MO, Vale W. Notch-mediated epigenetic regulation is critical for maintenance of pancreatic endocrine progenitors via possible integration with HB-EGF and CRF-family. The 6th San Diego Beta Cell Society Meeting UCSD 2010.11.07 San Diego

  12. Matsumoto M. Notch-mediated epigenetic regulation is critical for maintenance of pancreatic endocrine progenitors via possible integration with HB-EGF and CRF-family. The 6th San Diego Beta Cell Society Meeting 2010.11 UCSD, USA

  13. Matsumoto M. Regulation of pancreatic endocrine cell development by integration between a growth factor and Notch signaling cascades.. Keystone Symposia 2008.01.30

  14. Matsumoto M. Regulation of pancreatic endocrine cell development by integration between a growth factor and Notch signaling cascades. Keystone Symposia 2008.01 Salt Lake, USA

  15. Matsumoto M. Identification of a factor that supports differentiation of pancreatic endocrine cells mediated by a negative feed back regulation of Ngn3. Keystone Symposia 2006.03.08

  16. Matsumoto M. Identification of a factor that supports differentiation of pancreatic endocrine cells mediated by a negative feed back regulation of Ngn3. Keystone Symposia, 2006.03 New Mexico, USA

▼display all

 

Performance of duties 【 display / non-display

  • ,2020.04 - Now

  • ,2020.04 - Now

  • ,2004.04 - 2009.12